Wegovy and Zepbound are both FDA-approved, once-weekly injections for chronic weight management, and both work by quieting appetite. The difference is the molecule inside, and that difference shapes results, tolerance and cost. Here is how to weigh them without letting a single average make the decision for you.
Different molecules, different mechanisms
Wegovy is branded semaglutide, which acts on one gut-hormone receptor (GLP-1). Zepbound is branded tirzepatide, which acts on two (GIP and GLP-1). That dual action is thought to explain why tirzepatide produced larger average weight loss in trials.
What the trials showed
In the STEP 1 trial, adults without diabetes lost on average about 15% of their body weight over 68 weeks on semaglutide 2.4 mg. In SURMOUNT-1, adults on the top dose of tirzepatide lost on average about 20.9% over 72 weeks. A higher-dose Wegovy (semaglutide 7.2 mg, FDA-approved March 2026) averaged about 20.7% in the STEP UP trial, narrowing that gap.
Sources: STEP 1 (Wilding et al., NEJM 2021); SURMOUNT-1 (Jastreboff et al., NEJM 2022); STEP UP high-dose semaglutide (Novo Nordisk, 2026). Trial figures are population averages. Individual results vary.
Why the average is not the answer
A higher average across thousands of people does not tell you which medication you will tolerate, which your plan will cover, or which fits your medical history and goals. Some patients do beautifully on semaglutide, which has the longer track record. Others plateau on it and benefit from tirzepatide's dual mechanism. Both share the same main side effects (gastrointestinal, mildest at the lowest dose) and the same boxed warning about thyroid C-cell tumors seen in rodents; both are avoided in anyone with a personal or family history of medullary thyroid cancer or MEN2.
How coverage often decides
In practice, cost depends far more on your insurance than on the molecule. When a plan covers a branded GLP-1, either is usually a copay. Without coverage, each manufacturer has a self-pay path (NovoCare for Wegovy, LillyDirect for Zepbound) whose pricing changes over time. We verify your specific benefits and explain current options before you start. We prescribe branded medications only, never compounded.
How we choose with you
Dr. Eduardo weighs your goal and timeline, how your body handles side effects, your medical history, what your insurance covers, and whether surgery might be the better long-term fit. The right choice is the one that fits you, decided with a physician, not a chart.
Keep reading
Medically reviewed by Dr. Roger Eduardo, MD, FASMBS, Board-Certified General Surgeon. This article is for general education and is not a substitute for personalized medical advice. Individual results vary. Omnia Health prescribes branded, FDA-approved medications only, never compounded.
